Steroid Resistance in COPD? Overlap and Differential Anti-Inflammatory Effects in Smokers and Ex-Smokers

BACKGROUND: Inhaled corticosteroids (ICS) reduce exacerbation rates and improve health status but can increase the risk of pneumonia in COPD. The GLUCOLD study, investigating patients with mild-to-moderate COPD, has shown that long-term (2.5-year) ICS therapy induces anti-inflammatory effects. The l...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoonhorst, Susan J. M., ten Hacken, Nick H. T., Vonk, Judith M., Timens, Wim, Hiemstra, Pieter S., Lapperre, Thérèse S., Sterk, Peter J., Postma, Dirkje S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914834/
https://www.ncbi.nlm.nih.gov/pubmed/24505290
http://dx.doi.org/10.1371/journal.pone.0087443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914834/
https://www.ncbi.nlm.nih.gov/pubmed/24505290
http://dx.doi.org/10.1371/journal.pone.0087443

Ejemplares similares